BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 4, 2014
View Archived Issues
Baxter restructures agreement with Xenetic Biosciences and provides pipeline update
Read More
Researchers characterize antifungal activity EV-086
Read More
Glycopolymers used to uncover the mechanistic basis of tumor immunoprotection
Read More
Pazopanib demonstrates activity in patients with germ cell tumors
Read More
Sorafenib activity limited in patients with germ cell tumors
Read More
Chugai Pharmaceutical presents highlights of fourth quarter 2013
Read More
Phase II/III trial of Stallergenes' house dust mite immunotherapy tablets meets primary endpoint
Read More
AstraZeneca completes purchase of Bristol-Myers Squibb's global diabetes business
Read More
Burnet Institute receives grant to evaluate HIV test
Read More
Portola enters second collaboration with Bayer and Janssen for andexanet alfa
Read More
Chinese researchers present novel acetylcholinesterase inhibitors for Alzheimer's disease
Read More
New chimeric proteins patented by Biogen Idec and Amunix Operating
Read More
Omeros reports data from phase I trial of OMS-721
Read More
Phase Ib trial evaluates ONT-380 in breast cancer
Read More
Yong Guang Pharmaceutical discloses novel agents for cancer
Read More
U.S. group claims new HDAC4 inhibitors for Huntington's disease
Read More
Scientists in China synthesize new CETP inhibitors
Read More
Grastek obtains approval in Canada for grass pollen-induced allergic rhinitis
Read More
Tecfidera obtains approval in Europe for multiple sclerosis
Read More
Agios Pharmaceuticals opts for U.S. rights to IDH1 program
Read More
U.S. Navy approves phase I trial of Multikine in patients with HIV/HPV and perianal warts
Read More
FDA grants breakthrough therapy designation to eltrombopag
Read More
Tetrandrine demonstrates ability to protect against Ebola virus challenge in vivo
Read More
Ferrer collaborates with Ergomed and Ildong Pharmaceuticals for lorediplon
Read More
Kyowa Hakko Kirin initiates phase III study of ARQ-197 for HCC in Japan
Read More
Dainippon Sumitomo Pharma offers overview of third quarter of fiscal 2013
Read More